11/18/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:50 PM | Aldeyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
10/21/2024
7:22 PM | Aldeyra Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:15 PM | Aldeyra Therapeutics (Issuer)
Alfieri Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
8:02 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
3:24 PM | Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/14/2024
3:24 PM | Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
5:07 PM | Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
4:45 PM | Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
6:06 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
11:15 PM | Aldeyra Therapeutics (Filer)
| Form EFFECT | |
04/22/2024
3:11 PM | Aldeyra Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:13 PM | Aldeyra Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:18 PM | Aldeyra Therapeutics (Filer)
| Form ARS | |
04/08/2024
4:32 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:22 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:01 PM | Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:04 PM | Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:07 PM | Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:11 PM | Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
7:43 PM | Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
6:12 PM | Aldeyra Therapeutics (Subject)
Brady Todd C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:48 PM | Aldeyra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
3:40 PM | Aldeyra Therapeutics (Filer)
| Form S-8 POS | |
01/04/2024
6:00 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
6:05 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
6:16 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
